Ulcerative Colitis in Remission
9
2
2
3
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
11.1%
1 terminated out of 9 trials
75.0%
-11.5% vs benchmark
11%
1 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (9)
Evaluation of ProLife 10 FORTE on Gut Microbiota Composition in UC Patients
Effect of Procyanidins in Leaky Gut Repairing in IBD
Impact of Bread Diet on Intestinal Dysbiosis and Irritable Bowel Syndrome Symptoms in Quiescent Ulcerative Colitis
Curcumin for Prevention of Relapse in Patients With Ulcerative Colitis
Objective Perfusion Rate Assessment by Near-infrared Fluorescence in Ileal Pouch Formation and Ileal-pouch-anal Anastomosis
Predicting Relapse of Ulcerative Colitis With Gastrointestinal Ultrasound
A Multicenter Prospective Cohort Study on the Clinical Prognosis of Ulcerative Colitis
Comparative Efficacy and Safety Study in Patients With Ulcerative Colitis in Remission Phase
Nutritional State and Intake Nutrients Assessment in Ulcerative Colitis